Taken together, in the light of the correlation between ATF3 and DAS-28 score, the relationship between ATF3 expression and methotrexate/tocilizumab response, and the change of ATF3 expression after tocilizumab treatment, we assumed that ATF3 expression in the synovium might promote RA progression. This evidence concerns the gene ATF3 and rheumatoid arthritis.